Cargando…
免疫检查点抑制剂相关性重症肌无力：从诊断到治疗
Immune checkpoint inhibitor (ICI) has been proven to be a major breakthrough in the treatment of various tumor types. Despite the favorable results in terms of oncological outcomes, these treatments have been associated with a variety of immune-related adverse events (irAEs). Myasthenia gravis (MG)...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467994/ https://www.ncbi.nlm.nih.gov/pubmed/32752585 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.25 |